NEW YORK — July 8, 2022 — Berkery Noyes, an independent mid-market investment bank, today released its half year 2022 mergers and acquisitions trend report for the Healthcare/Pharma Information and Technology Industry.

The report analyzes M&A activity during the first half of 2022 and compares it with the four previous six-month periods from 2020 to 2021. This market includes information, technology, digital, and services companies utilized by the pharmaceutical, healthcare payer, and healthcare provider spaces.

Total transaction volume in 1st Half 2022 declined by two percent over 2nd Half 2021, from 246 to 240. Total transaction value in 1st Half 2022 fell by 75 percent over 2nd Half 2021, from $67.54 billion to $16.73 billion. Of note, value more than doubled from 1st Half 2021 to 2nd Half 2021.

Deal activity in the Healthcare Business Services segment improved 33 percent on a half year basis. The largest transaction in the segment and overall industry during 1st Half 2022 was R1 RCM’s acquisition of Cloudmed, which specializes in healthcare revenue intelligence solutions that automate the analysis of large volumes of medical records, payment data, and complex insurance models, for $4.09 billion.

M&A volume in the Healthcare IT segment decreased 17 percent over the past six months. Notable segment transactions year-to-date included Stryker Corporation’s acquisition of Vocera Communications, a provider of clinical communication and workflow solutions, for $2.9 billion; and Zebra Technologies Corporation’s acquisition of Matrox Imaging division from Matrox Electronic Systems for $875 million.

A copy of the HEALTHCARE/PHARMA INFORMATION AND TECHNOLOGY INDUSTRY M&A REPORT FOR HALF YEAR 2022 is available at the Berkery Noyes website.